Gambling disorder has long been classified strictly as a psychiatric condition, but new scientific research suggests its harm extends far beyond psychological distress. In a narrative review published in the journal Clinics and Practice, researchers argue that compulsive gambling operates as a full-body medical condition, driving systemic physical morbidity across multiple organ systems and substantially elevating the risk for chronic, life-threatening diseases.
Beyond the Mind: A Hidden Physical Burden
Historically framed solely as a behavioral addiction, gambling disorder has had its physical health consequences routinely overlooked in standard clinical evaluations. To address this oversight, researchers Martina Ballerio, Piercarlo Minoretti, and Enzo Emanuele synthesized cross-sectional and prospective evidence to identify a distinct somatic phenotype spanning four major bodily axes: cardiovascular, metabolic, sleep-related, and neurological.
According to the study, individuals living with the condition exhibit heightened rates of severe cardiovascular complications, including hypertension, angina, stroke, and acute stress-induced cardiac events. The metabolic axis reveals a heavy burden of obesity, type 2 diabetes, and chronic liver disease, while sleep architecture is frequently undermined by severe insomnia, poor sleep quality, and chronic daytime exhaustion. Additionally, the review identified an emerging neurological dimension, highlighting clinical clustering between compulsive gambling, seizures, and frontal lobe epilepsy.
How Addiction Rewires the Body
The authors outlined three candidate biological systems that translate repetitive gambling behaviors into widespread physiological damage. First, a hyperreactive mesostriatal reward circuit frequently sustains a destructive cluster of lifestyle habits, including heavy tobacco use, hazardous alcohol intake, physical inactivity, and poor nutrition.
Second, sustained psychological distress disrupts the body’s integrated stress response. The authors note that prolonged gambling exposure appears to shift stress pathways from acute hyperreactivity to blunted baseline cortisol levels and diminished vagal tone. This neuroendocrine fatigue accelerates cumulative allostatic load, the multi-system wear and tear caused by chronic physiological strain.
Third, the study identified altered peripheral signaling and structural brain changes, marked by elevated circulating levels of brain-derived neurotrophic factor (BDNF) alongside microstructural abnormalities in frontal-callosal white matter. These markers suggest that the relentless stress of addiction actively destabilizes pathways connecting neural processing to peripheral bodily health.
A Dual-Front Treatment Strategy
Recognizing gambling disorder as a systemic medical illness demands a fundamental shift in patient care. The authors argue that effective clinical management requires close collaboration between addiction psychiatrists and internal medicine specialists to screen for and treat underlying cardiometabolic and neurological complications.
This biological perspective also points toward promising medical treatments. The authors put forward glucagon-like peptide-1 (GLP-1) receptor agonists—popular medications widely used to treat diabetes and obesity—as a compelling therapeutic candidate. Because GLP-1 agonists target mesolimbic reward pathways while improving metabolic, hepatic, and cardiovascular health, they could uniquely address both the compulsive behavior and its bodily fallout.
Study Scope and Future Directions
The researchers emphasize that their work represents a narrative, hypothesis-generating review rather than definitive proof of direct biological causality. The synthesized evidence relies largely on existing observational datasets. Dedicated prospective clinical trials will be essential to validate these proposed biological pathways and formally assess whether pharmacotherapies such as GLP-1 receptor agonists can effectively treat gambling disorder in clinical practice.
Source
- Gambling Disorder as a Behaviorally Driven Systemic Medical Condition: From Reward Circuitry to Multi-System Morbidity
- Researchers: Martina Ballerio, Piercarlo Minoretti, Enzo Emanuele
- Journal: Clinics and Practice
- Read the original study